Sergio Giralt, MD
Hematology & Oncology · New York, NYNPI 1639278880
Payments from drug & device makers
Across 225 payments — averaging $29,816 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$6.2M
- National Marrow Donor Program$108K
- Sanofi-aventis U.S. LLC$74K
- Gilead$67K
- Pfizer$45K
- Omeros Corporation$38K
- plus $151K from 23 others
Across 9 payments — averaging $1487.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Omeros Corporation$8K
- Pfizer$5K
- Novartis$800
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 19 | $6,225,326 |
| National Marrow Donor Program | 8 | $107,974 |
| Sanofi-aventis U.S. LLC | 16 | $74,071 |
| Gilead | 35 | $66,673 |
| Pfizer(2 entities) | 13 | $44,850 |
| Omeros Corporation | 20 | $38,335 |
| CSL Behring | 22 | $36,981 |
| Incyte Corporation | 30 | $33,110 |
| E.r. Squibb & Sons, L.L.C. | 5 | $13,206 |
| Amgen | 17 | $12,094 |
| Gamida Cell Inc. | 1 | $9,120 |
| Regeneron | 7 | $7,051 |
| Janssen Global Services, LLC | 7 | $6,313 |
| Daiichi Sankyo Inc. | 6 | $5,918 |
| Novartis | 2 | $5,502 |
| Swedish Orphan Biovitrum AB | 1 | $4,250 |
| Secura Bio, Inc. | 1 | $3,750 |
| Partner Therapeutics, Inc. | 2 | $2,498 |
| Medexus Pharma, Inc. | 1 | $2,040 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $2,000 |
| Dr.reddy's Laboratories,inc. | 1 | $2,000 |
| GSK | 1 | $1,950 |
| Kadmon Pharmaceuticals LLC | 1 | $1,605 |
| EUSA Pharma (US) LLC | 1 | $1,500 |
| Karyopharm Therapeutics Inc. | 3 | $300 |
| Sanofi | 1 | $103 |
| Autolus Inc | 1 | $38 |
| Johnson & Johnson | 1 | $38 |
| Grifols Shared Services North America, Inc. | 1 | $17 |
How this compares
$6,708,613 in reported general payments places this provider in the 95th percentile of 967 hematology & oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in New York
- Vicky MakkerNew York$27.1M
- Alison MoskowitzNew York$22.7M
- Ajai ChariNew York$22.4M
- Yelena JanjigianNew York$16.9M
- Alexander LesokhinNew York$11.9M
- John MascarenhasNew York$11.8M
- Maria PalombaNew York$11.6M
- Scott TagawaNew York$10.3M
- Mohammad Abdul HayNew York$9.9M
- Joshua SabariNew York$9.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.